Conference Coverage
NewsNetwork
OncLive TV
PEER EXCHANGE
OncLive INSIGHTS
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
More >>
<< View all publications

Special Issues

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies
The Rationale for Bruton Tyrosine Kinase Inhibition in B-Cell Lymphomas   >   Articles
BTK Inhibitors: Real-World Insights on Patient Management and Therapy Selection
BTK Inhibitors: Real-World Insights on Patient Management and Therapy Selection
The Rationale for Bruton Tyrosine Kinase Inhibition in B-Cell Lymphomas   >   Articles
The Changing Treatment Landscape in MCL and CLL: A Review of Standards of Care
The Changing Treatment Landscape in MCL and CLL: A Review of Standards of Care
The Rationale for Bruton Tyrosine Kinase Inhibition in B-Cell Lymphomas   >   Articles
Expert Highlights Role of TMB in Evolving Immuno-Oncology Landscape
Expert Highlights Role of TMB in Evolving Immuno-Oncology Landscape
Focus on Pathways: Next-Generation Sequencing to Support Immuno-Oncology Therapy: The Emerging Role of Tumor Mutational Burden   >   Articles
Next-Generation Sequencing to Support Immuno-Oncology Therapy: The Emerging Role of Tumor Mutation Burden
Next-Generation Sequencing to Support Immuno-Oncology Therapy: The Emerging Role of Tumor Mutation Burden
Focus on Pathways: Next-Generation Sequencing to Support Immuno-Oncology Therapy: The Emerging Role of Tumor Mutational Burden   >   Articles
Emerging Mutations in Lung Cancer and Other Solid Tumors
Emerging Mutations in Lung Cancer and Other Solid Tumors
Focus on Pathways: Emerging Mutations in Lung Cancer and Other Solid Tumors   >   Articles
Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology
Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology
Focus on Pathways: Therapeutic Inhibition of XPO1- Mediated Nucleocytoplasmic Transport With SINE Technology   >   Articles
NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy
NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy
Focus on Pathways: NTRK Gene Fusions   >   Articles
Polatuzumab Vedotin Plus R-CHOP Being Explored in DLBCL Trial
Polatuzumab Vedotin Plus R-CHOP Being Explored in DLBCL Trial
Focus on Pathways: Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma   >   Articles
Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma
Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma
Focus on Pathways: Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma   >   Articles
Next Page >>
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
Publication Bottom Border
Border Publication
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.
 
x